ESC Professional Premium Access

Early interventions to promote healthy lifestyle and risk factor control in subjects with elevated cardiovascular risk. A 3-year randomized clinical trial

Congress Presentation

About the speaker

Doctor Hilde Marie Bergum

LHL Hospital, Jessheim (Norway)
0 follower

7 more presentations in this session

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Speaker: Doctor S. Hageman (Utrecht, NL)


Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility - a coronary calcium score correlation study

Speaker: Miss M. Paiva (Lisbon, PT)


Associations of SCORE2, circulating cardiovascular biomarkers and carotid intima-media-thickness in a population-based cohort

Speaker: Doctor B. Toprak (Hamburg, DE)


Comparison between the European SCORE and the updated SCORE2 for cardiovascular outcomes

Speaker: Doctor M. Temtem (Funchal, PT)


Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Speaker: Doctor A. Yari (Stockholm, SE)


Access the full session

Cardiovascular risk assessment and scores

Speakers: Doctor H. Bergum, Doctor S. Hageman, Miss M. Paiva, Doctor B. Toprak, Doctor M. Temtem...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb